We are live on ! Find out more
TGI

TRV GP IV Portfolio holdings

AUM $267M
1-Year Est. Return 965.83%
This Fund
S&P 500
This Quarter Est. Return
+8.9%
1 Year Est. Return
+965.83%
3 Year Est. Return
+686.22%
5 Year Est. Return
+581.56%
10 Year Est. Return
AUM
$312M
AUM Growth
+$21.2M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLAY icon
1
Relay Therapeutics
RLAY
$4.1B
$117M 37.48%
2,811,197
DNTH icon
2
Dianthus Therapeutics
DNTH
$5.84B
$62.8M 20.14%
500,513
RVMD icon
3
Revolution Medicines
RVMD
$39.9B
$56.2M 18.03%
1,419,900
PLRX icon
4
Pliant Therapeutics
PLRX
$64.4M
$48.5M 15.55%
2,132,867
FULC icon
5
Fulcrum Therapeutics
FULC
$273M
$27.4M 8.8%
2,343,154

Similar funds

TRV GP IV's Q4 2020 Portfolio in Review

As of Q4 2020, TRV GP IV held 5 positions worth $312M, up 7.3% from $290M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2020: portfolio turnover was 0%. TRV GP IV opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP IV's ten largest holdings make up 100% of its $312M portfolio in Q4 2020.
  • TRV GP IV opened 0 new positions and closed 0 in Q4 2020.
  • TRV GP IV's portfolio value rose 7.3% quarter-over-quarter to $312M.

Based on TRV GP IV's 13F filing for Q4 2020, filed 16 Feb 2021.